Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
Data in this table is on a revised international merchandise trade basis. Data in this table is on a revised international merchandise trade basis and excludes value adjustments applied to balance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback